SUMMARY A 28-year-old man is described with no demonstrable organic heart disease and recurrent paroxysmal attacks of sustained ventricular tachycardia. Lignocaine and ajmaline failed to terminate the first attack but a bolus injection of verapamil succeeded. This drug was subsequently successful on six more occasions. During electrophysiological study of the eighth attack, slow intravenous administration of verapamil significantly reduced the rate of the tachycardia and prevented its subsequent reinitiation by pacing.
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Two mechanisms are postulated to explain both the arrhythmia and the beneficial effects of verapamil in this case.
Verapamil is a very effective, widely used antiarrhythmic agent in the treatment of supraventricular tachyarrhythmias.' 2 Little is known, however, about its efficacy in treating sustained ventricular tachycardia.
We report the successful use of verapamil in terminating or slowing sustained ventricular tachycardia, and in preventing its reinitiation by pacing. On the basis of the electrophysiological properties of verapamil, the possible pathogenesis of the arrhythmia is discussed.
Case report
A 28-year-old nman was admitted to hospital in March 1979 because of a recurrent attack of sustained ventricular tachycardia. He had experienced the first attack at the age of 18 and six additional attacks had occurred between October 1977 and the time of admission, for which he had been treated in another hospital. During the attacks the heart rate was 150 beats/mn and the electrocardiogram showed a right bundle-branch block pattern with left axis deviation, atrioventricular dissociation, sinus capture, and fusion beats, After the attacks, the electrocardiogram showed only transient repolarisation abnormalities in the posterolateral leads, probably post-tachycardia changes.
During the first attack in October 1977, lignocaine (100 mg intravenously) had had no effect while the administration of ajmaline (50 mg intravenously) had resulted in transient slowing of the arrhythmia from 150 to 125 beats/min. An intravenous bolus of verapamil (7-5 mg) administered one hour after aimaline restored sinus rhythm after progressive slowing of the tachycardia (Fig. 1) . Verapamil was the only drug administered in the six subsequent attacks and always terminated the tachycardia within three minutes of injection.
Maintenance treatment with oral quinidine sulphate (1200 mg/day) failed to prevent the attacks of tachycardia; this was attributed to the patient's non-compliance. Amiodarone hydrochloride (200 mg/ day) was taken more regularly and resulted in suppression of the tachycardia for 10 months until the occurrence of the attack for which he was admitted. On admission, physical examination was normal. The electrocardiogram showed a pattern similar to that of previous attacks.
An electrophysiological study, performed during the tachycardia, showed that the cycle length was 450 ms (rate: 133 beats/nun). No His potential was present before the QRS complex of the tachycardia; sinus capture beats were preceded by a His potential with an HV interval of 50 ms. During right atrial pacing at a rate of 143 beats/min, fusion beats were observed and the QRS complex returned to normal with a His potential preceding each QRS complex with an HV interval of 50 ms (Fig. 2) . When atrial pacing was ineffective or interrupted (Fig. 2) (Fig. 3) .
The chest x-ray film, the echocardiogram, and the radionuclide ventriculogram (99Tc) were all normal.
Maintenance oral verapamil treatment was recommended but the patient refused to take drugs three times a day. Amiodarone (400 mg once daily five days a week) was, therefore, continued and on this treatment one further attack occurred a year later which also responded to intravenous verapamil.
Discussion
The tachycardia in our patient fulfils all the generally accepted criteria of ventricular tachycardia. 
